When Investment for Medical Countermeasures against Rare, but Dangerous Agents Becomes Cost Effective – The Ebola Case
When Investment for Medical Countermeasures against Rare, but Dangerous Agents Becomes Cost Effective – The Ebola Case Cost Research Article: Economics surrounding the Ebola Outbreak (short version) Introduction: There are countless chemical, biological, radiological, and nuclear (CBRN) agents that are proficient enough to harm individuals. Examples include viruses (e.g. influenza) and bacteria which [...]